Exodus Point Capital Management, LP Shattuck Labs, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.6 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$3.0 - $4.85 $32,289 - $52,200
10,763 New
10,763 $38,000
Q1 2024

May 14, 2024
BUY
$7.37 - $10.09 $115,215 - $157,736
15,633 New
15,633 $140,000

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $44.9M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email